Status:
RECRUITING
Comorbidities Resolution After MGB Surgery and Change in Body Composition
Lead Sponsor:
All India Institute of Medical Sciences, Bhubaneswar
Conditions:
Morbid Obesity
Type2diabetes
Eligibility:
All Genders
18-65 years
Brief Summary
This observational study aims to learn about the correlation between the improving comorbidities associated with obesity after MGB (Mini-Gastric Bypass) surgery and changes in body composition in morb...
Detailed Description
Evidence supports that bariatric or metabolic surgery is more effective than conventional therapy in controlling obesity and its related comorbidities. Although bariatric surgery has been widely pract...
Eligibility Criteria
Inclusion
- All patients undergoing laparoscopic MGB surgery for morbid obesity and it's associated comorbidities
Exclusion
- Patients not giving consent for the study
- All patients who were undergoing a redo-procedure for recurrence were excluded from the study
Key Trial Info
Start Date :
September 1 2023
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
September 30 2026
Estimated Enrollment :
35 Patients enrolled
Trial Details
Trial ID
NCT06015620
Start Date
September 1 2023
End Date
September 30 2026
Last Update
September 5 2024
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
All India Institute of Medical Sciences
Bhubaneswar, Odisha, India, 751019